MIDD in Early Oncology Clinical Development: Dose Optimization

MIDD In Early Oncology Clinical Development : Dose Optimization & Beyond

MIDD In Early Oncology Clinical Development

Dose optimization is a necessary method to ensure patients receive the appropriate amount of medicine and an important consideration as part of a long development process. By leveraging Model-Informed Drug Development (MIDD), dose optimization creates a path to keeping oncology clinical trials on pace from an early stage.

Partner With the A-Team

Let us know how we can help you bring new therapies to light. Get in touch to get started.

Join the A-Team

Want to help small and mid-sized biotech companies change the therapeutic landscape?

Subscribe to our monthly newsletter